{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T15:02:04Z","timestamp":1789570924180,"version":"build-2803163510"},"reference-count":15,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T00:00:00Z","timestamp":1787616000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Forschung, Technologie und Raumfahrt","doi-asserted-by":"publisher","award":["01ZZ1804C"],"award-info":[{"award-number":["01ZZ1804C"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"DOI":"10.3389\/fneur.2026.1872262","type":"journal-article","created":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T04:23:42Z","timestamp":1787631822000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["From MRI activity to treatment escalation in relapsing multiple sclerosis: what can new T2 lesions tell us?"],"prefix":"10.3389","volume":"17","author":[{"given":"Stefan","family":"Buchka","sequence":"first","affiliation":[{"name":"Institute for Medical Information Processing, Biometry, and Epidemiology, Medical Faculty, Ludwig-Maximilians University Munich","place":["Munich, Germany"]},{"name":"Pettenkofer School of Public Health, Medical Faculty, Ludwig-Maximilians University Munich","place":["Munich, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich","family":"Mansmann","sequence":"additional","affiliation":[{"name":"Institute for Medical Information Processing, Biometry, and Epidemiology, Medical Faculty, Ludwig-Maximilians University Munich","place":["Munich, Germany"]},{"name":"Pettenkofer School of Public Health, Medical Faculty, Ludwig-Maximilians University Munich","place":["Munich, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joachim","family":"Havla","sequence":"additional","affiliation":[{"name":"Institute of Clinical Neuroimmunology, LMU University Hospital, LMU Medizin, Ludwig-Maximilians-Universit\u00e4t M\u00fcnchen","place":["Munich, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,8,25]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"3116","DOI":"10.1007\/s00415-024-12305-4","article-title":"Early use of high-efficacy therapies in multiple sclerosis in the United States: benefits, barriers, and strategies for encouraging adoption","volume":"271","author":"Singer","year":"2024","journal-title":"J Neurol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1212\/CPJ.0000000000000254","article-title":"Consensus opinion of US neurologists on practice patterns in RIS, CIS, and RRMS: evolution of treatment practices","volume":"6","author":"Tornatore","year":"2016","journal-title":"Neurol Clin Pract."},{"key":"B3","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1017\/cjn.2020.66","article-title":"Treatment optimization in multiple sclerosis: Canadian MS working group recommendations","volume":"47","author":"Freedman","year":"2020","journal-title":"Can J Neurol Sci."},{"key":"B4","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/S1474-4422(21)00095-8","article-title":"2021 MAGNIMS\u2013CMSC\u2013NAIMS consensus recommendations on the use of MRI in patients with multiple sclerosis","volume":"20","author":"Wattjes","year":"2021","journal-title":"Lancet Neurol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"17562864241229325","DOI":"10.1177\/17562864241229325","article-title":"Prognostic relevance of MRI in early relapsing multiple sclerosis: ready to guide treatment decision making?","volume":"17","author":"Hoffmann","year":"2024","journal-title":"Ther Adv Neurol Disord."},{"key":"B6","doi-asserted-by":"publisher","first-page":"11795735261453967","DOI":"10.1177\/11795735261453967","article-title":"Correlation is not prediction: reassessing predictive MRI evidence in guidelines for persons with relapsing-remitting multiple sclerosis","volume":"18","author":"Minas","year":"2026","journal-title":"J Cent Nerv Syst Dis."},{"key":"B7","doi-asserted-by":"publisher","first-page":"e0337893","DOI":"10.1371\/journal.pone.0337893","article-title":"Individual-level surrogacy of MRI lesions for disease severity in RRMS: methods to quantify predictive power and their application to longitudinal data from recent trials","volume":"20","author":"Buchka","year":"2025","journal-title":"PLoS ONE."},{"key":"B8","doi-asserted-by":"publisher","first-page":"106247","DOI":"10.1016\/j.msard.2024.106247","article-title":"Multivariable prognostic prediction of efficacy and safety outcomes and response to fingolimod in people with relapsing-remitting multiple sclerosis","volume":"93","author":"\u00d6n","year":"2025","journal-title":"Mult Scler Relat Disord."},{"key":"B9","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1177\/1352458507085555","article-title":"Relationship between MRI lesion activity and response to IFN-\u03b2 in relapsing\u2013remitting multiple sclerosis patients","volume":"14","author":"Rio","year":"2008","journal-title":"Mult Scler J."},{"key":"B10","doi-asserted-by":"publisher","first-page":"DC013606","DOI":"10.1002\/14651858.CD013606.pub2","article-title":"Prognostic models for predicting clinical disease progression, worsening and activity in people with multiple sclerosis","volume":"9","year":"2023","journal-title":"Cochrane Database Syst Rev."},{"key":"B11","doi-asserted-by":"publisher","first-page":"101928","DOI":"10.1016\/j.msard.2020.101928","article-title":"Predictive medicine in multiple sclerosis: a systematic review","volume":"40","author":"Havas","year":"2020","journal-title":"Mult Scler Relat Disord."},{"key":"B12","author":"Hern\u00e1n","year":"2023","journal-title":"Causal Inference: What If. 1st Edn. Boca Raton, FL: Taylor and Francis"},{"key":"B13","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1186\/s12916-025-03994-3","article-title":"The validation of prediction models deserves more recognition","volume":"23","author":"Mansmann","year":"2025","journal-title":"BMC Med."},{"key":"B14","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1186\/s12874-024-02264-9","article-title":"Framework for personalized prediction of treatment response in relapsing-remitting multiple sclerosis: a replication study in independent data","volume":"24","author":"Sakr","year":"2024","journal-title":"BMC Med Res Methodol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1177\/0272989X06295361","article-title":"Decision curve analysis: a novel method for evaluating prediction models","volume":"26","author":"Vickers","year":"2006","journal-title":"Med Decis Making."}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2026.1872262\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T14:02:17Z","timestamp":1789567337000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2026.1872262\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,25]]},"references-count":15,"alternative-id":["10.3389\/fneur.2026.1872262"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2026.1872262","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,25]]},"article-number":"1872262"}}